2.70
price up icon4.25%   0.11
after-market After Hours: 2.71 0.010 +0.37%
loading
Aadi Bioscience Inc stock is traded at $2.70, with a volume of 129.74K. It is up +4.25% in the last 24 hours and down -9.40% over the past month. Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
See More
Previous Close:
$2.59
Open:
$2.6
24h Volume:
129.74K
Relative Volume:
0.40
Market Cap:
$66.68M
Revenue:
$23.26M
Net Income/Loss:
$-63.41M
P/E Ratio:
-1.1441
EPS:
-2.36
Net Cash Flow:
$-64.56M
1W Performance:
+0.00%
1M Performance:
-9.40%
6M Performance:
+83.67%
1Y Performance:
+42.11%
1-Day Range:
Value
$2.59
$2.71
1-Week Range:
Value
$2.56
$2.71
52-Week Range:
Value
$1.21
$3.812

Aadi Bioscience Inc Stock (AADI) Company Profile

Name
Name
Aadi Bioscience Inc
Name
Phone
424-473-8055
Name
Address
17383 SUNSET AVENUE, PACIFIC PALISADES
Name
Employee
53
Name
Twitter
Name
Next Earnings Date
2024-12-06
Name
Latest SEC Filings
Name
AADI's Discussions on Twitter

Compare AADI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AADI
Aadi Bioscience Inc
2.70 66.68M 23.26M -63.41M -64.56M -2.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.11 118.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.00 74.34B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
639.00 38.83B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.00 32.36B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.75 29.43B 3.30B -501.07M 1.03B -2.1146

Aadi Bioscience Inc Stock (AADI) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-27-24 Downgrade Piper Sandler Overweight → Neutral
Aug-21-24 Downgrade Jefferies Buy → Hold
Aug-21-24 Downgrade TD Cowen Buy → Hold
Dec-15-23 Downgrade H.C. Wainwright Buy → Neutral
Jan-11-22 Initiated Jefferies Buy
Oct-01-21 Initiated Cowen Outperform
Sep-14-21 Initiated Ladenburg Thalmann Buy
Sep-08-21 Initiated Piper Sandler Overweight
View All

Aadi Bioscience Inc Stock (AADI) Latest News

pulisher
Feb 18, 2025

Aadi Bioscience names new CSO to advance ADC pipeline - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer - PR Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

Peapod Lane Capital LLC Makes New $1.40 Million Investment in Aadi Bioscience, Inc. (NASDAQ:AADI) - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Growth in Short Interest - MarketBeat

Feb 16, 2025
pulisher
Feb 13, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Update - Defense World

Feb 13, 2025
pulisher
Feb 06, 2025

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Declines By 13.7% - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 - Quantisnow

Feb 05, 2025
pulisher
Feb 05, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Decrease in Short Interest - Defense World

Feb 05, 2025
pulisher
Feb 02, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Large Growth in Short Interest - MarketBeat

Feb 02, 2025
pulisher
Jan 29, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Large Increase in Short Interest - Defense World

Jan 29, 2025
pulisher
Jan 24, 2025

ACUTA CAPITAL PARTNERS, LLC Expands Stake in Aadi Bioscience Inc - GuruFocus.com

Jan 24, 2025
pulisher
Jan 16, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Position Lowered by Jane Street Group LLC - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Aadi Bioscience, Inc. (NASDAQ:AADI) Shares Sold by Jane Street Group LLC - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Rises By 136.0% - Defense World

Jan 16, 2025
pulisher
Jan 14, 2025

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Grows By 136.0% - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Aadi Bioscience (NASDAQ:AADI) Shares Down 16.1% – What’s Next? - Defense World

Jan 14, 2025
pulisher
Jan 14, 2025

Aadi Bioscience (NASDAQ:AADI) Trading Down 16.1%What's Next? - MarketBeat

Jan 14, 2025
pulisher
Dec 23, 2024

Aadi Bioscience Enters Into Multiple Strategic Agreements, Including $100M Stock Purchase and License Agreement - Defense World

Dec 23, 2024
pulisher
Dec 23, 2024

Aadi Bioscience, Inc. announced that it expects to receive $100.002392 million in funding from a group of investors - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

Aadi Bioscience Sale of FYARRO® to Kaken Pharmaceutical and In-Licensing of Novel ADC Portfolio from WuXi Biologics - Leerink Partners

Dec 23, 2024
pulisher
Dec 23, 2024

Aadi Bioscience Leads 3 Promising US Penny Stocks - Simply Wall St

Dec 23, 2024
pulisher
Dec 21, 2024

Aadi Bioscience rockets 72% on key updates - MSN

Dec 21, 2024
pulisher
Dec 21, 2024

Aadi Bioscience’s Strategic Agreements and Funding Moves - Yahoo Finance

Dec 21, 2024
pulisher
Dec 20, 2024

Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio - Wilson Sonsini

Dec 20, 2024
pulisher
Dec 20, 2024

Asia Deal Watch: Kaken Obtains Aadi Subsidiary And Cancer Drug Fyarro - Citeline

Dec 20, 2024
pulisher
Dec 20, 2024

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday? - Benzinga

Dec 20, 2024
pulisher
Dec 20, 2024

Aadi Bioscience stock soars on licensing and sale deals - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 20, 2024
pulisher
Dec 19, 2024

Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing - Yahoo Finance

Dec 19, 2024
pulisher
Dec 19, 2024

Kaken Pharmaceutical Co., Ltd. agreed to acquire Aadi Subsidiary, Inc. from Aadi Bioscience, Inc. for $100 million. - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Clinical Trials News Live Feed - StockTitan

Dec 19, 2024
pulisher
Dec 11, 2024

AADI Enlists NY Court To Enforce Cancer Drug Award - Law360

Dec 11, 2024
pulisher
Dec 03, 2024

Aadi Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 03, 2024
pulisher
Dec 02, 2024

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Decreases By 8.8% - MarketBeat

Dec 02, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Cuts Stake in Aadi Bioscience, Inc. (NASDAQ:AADI) - Defense World

Nov 26, 2024
pulisher
Nov 19, 2024

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 19, 2024
pulisher
Nov 12, 2024

US Penny Stocks Under $90M Market Cap To Watch - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

BML Capital Management LLC Takes $4.12 Million Position in Aadi Bioscience, Inc. (NASDAQ:AADI) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Aadi Bioscience Reports Q3 2024 Earnings and Growth - TipRanks

Nov 11, 2024
pulisher
Nov 08, 2024

Aadi Bioscience Faces Potential Financial Strain from Securities Class Action Risks - TipRanks

Nov 08, 2024
pulisher
Nov 06, 2024

Aadi Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada

Nov 06, 2024

Aadi Bioscience Inc Stock (AADI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$32.85
price up icon 1.51%
$81.36
price up icon 2.58%
$21.08
price down icon 1.36%
$372.83
price up icon 0.61%
biotechnology ONC
$238.11
price up icon 3.14%
$122.75
price up icon 2.44%
Cap:     |  Volume (24h):